Vitamin D receptor expression is required for growth modulation by 1α,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31
- 1 June 1996
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 58 (3), 277-288
- https://doi.org/10.1016/0960-0760(96)00030-1
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell linesEndocrinology, 1993
- Beneficial Effects of Sun Exposure on Cancer MortalityPreventive Medicine, 1993
- Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiationCancer, 1992
- Active cell death in hormone-dependent tissuesCancer and Metastasis Reviews, 1992
- Rapid actions of vitamin D compoundsJournal of Cellular Biochemistry, 1992
- Sunlight and Breast Cancer Incidence in the USSRInternational Journal of Epidemiology, 1990
- Role of calcium in the programmed death of rat prostatic glandular cellsThe Prostate, 1990
- POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATIONThe Lancet, 1989
- DIETARY VITAMIN D AND CALCIUM AND RISK OF COLORECTAL CANCER: A 19-YEAR PROSPECTIVE STUDY IN MENThe Lancet, 1985
- Do Sunlight and Vitamin D Reduce the Likelihood of Colon Cancer?International Journal of Epidemiology, 1980